|The ADAM19 adam19 (Catalog #MBS9228421) is a Blocking Peptide and is intended for research purposes only. The product is available for immediate purchase.
The ADAM19 adam19 product has the following accession number(s) (GI #302393821) (NCBI Accession #Q9H013.3) (Uniprot Accession #Q9H013). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Participates in the proteolytic processing of beta-type neuregulin isoforms which are involved in neurogenesis and synaptogenesis, suggesting a regulatory role in glial cell. Also cleaves alpha-2 macroglobulin. May be involved in osteoblast differentiation and/or osteoblast activity in bone (By similarity).
Cellular Location: Membrane; Single-pass type I membrane protein. Tissue Location: Expressed in many normal organ tissues and several cancer cell lines. Brain Diseases, Cardiovascular Diseases, Disease Models, Animal, Fibrosis, Inflammation, Kidney Diseases, Lung Neoplasms, Necrosis, Nervous System Diseases, Ovarian Neoplasms are some of the diseases may be linked to ADAM19 Antibody (Center) Blocking Peptide. ADAM19 also interacts with the following gene(s): FURIN, NRG1. Blood, Bone, Brain, Embryonic Tissue, Heart, Kidney, Lung, Lymph Node, Placenta, Vascular tissues are correlated with this protein.